Fusion Antibodies Ltd 
Fusion Antibodies offer a range of highly competitive services in the antibody drug discovery and development space. We specialise in production of monoclonal antibodies, antibody engineering, antibody humanization, antibody sequencing, stable cell line development and antibody expression. With 15+ years of experience in the medical research industry, including two of our own Antibodies in clinical and pre-clinical trials, Fusion Antibodies is a world-wide industry leader in therapeutic and diagnostic antibody development.
Dr Paul Kerr
Managing Director
